Companies push ahead on cannabis-infused gummy plans despite hazy regulations

  • 📰 globeandmail
  • ⏱ Reading Time:
  • 45 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 21%
  • Publisher: 92%

Sverige Nyheter Nyheter

Sverige Senaste nytt,Sverige Rubriker

Companies push ahead on cannabis-infused gummy plans despite hazy regulations GlobeBusiness

. The rules laid out so far are aimed at keeping the new pot products out of the hands of kids and stipulate they can’t be seen as “appealing to young persons” – but Health Canada has yet to provide additional details on exactly what crosses the line.

The earliest new goods can be sold legally will be mid-December, due to the required 60-day notice companies must provide to Health Canada of their intent to sell them. In the U.S., where edibles are already available in several states where recreational pot is legalized, gummies are more popular than ever, according to BDS Analytics.

The risks to children of such products were outlined in recent research by the Canadian Paediatric Society, which found that a “significant number of young children” required medical care after ingesting cannabis in the months surrounding legalization last October.The preliminary research found 16 reported cases involving recreational pot between September and December 2018.

“It will be a significant impact,” said Malkani, noting that gummies are expected to account for roughly eight or nine per cent of edibles in Quebec.

 

Tack för din kommentar. Din kommentar kommer att publiceras efter att ha granskats.
Vi har sammanfattat den här nyheten så att du kan läsa den snabbt. Om du är intresserad av nyheterna kan du läsa hela texten här. Läs mer:

 /  🏆 5. in SE

Sverige Senaste nytt, Sverige Rubriker

Similar News:Du kan också läsa nyheter som liknar den här som vi har samlat in från andra nyhetskällor.

Pharmaceutical companies file constitutional challenge to Canada’s new drug price regulationsCompanies have said lower prices will make international drug manufacturers less likely to bring new medications to Canada.
Källa: globeandmail - 🏆 5. / 92 Läs mer »